ESR1 and breast cancer: Likewise, the comparison of estrogen-receptor (ER) negative breast cancer cell lines with high (MDA-MB-436) and low (MDA-MB-468) AnxA6 levels showed a 55.0% reduction in the number of caveolae in the ER-negative cells with high AnxA6 expression levels.